Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-18

Clinical Trial Update: Systems Biology Approach to Cognitive Impairment After SepsiS

View source ↗

Summary

A completed clinical trial investigating a systems biology approach to cognitive impairment following sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Sepsis, Cognitive Impairment | Status: COMPLETED